| 60 |
abnormal |
dendrite morphogenesis
(GO:0048813)
|
dendrite
(GO:0030425)
|
382: Aberrant, Dendritic morphology
|
| 321 |
abnormal |
calmodulin binding
(GO:0005516)
|
calcium ion
(CHEBI:39124)
|
1243: Altered, Ca2+-calmodulin activated signal transduction
|
| 371 |
abnormal |
chromosome movement towards spindle pole
(GO:0051305)
|
chromosome
(GO:0005694)
|
752: Altered, Meiotic chromosome dynamics
|
| 279 |
abnormal |
|
fetal proteins
(MESH:D005326)
|
661: Decreased testosterone by the fetal Leydig cells, Alterations in the fetal testis proteome
|
| 209 |
abnormal |
cell proliferation
(GO:0008283)
|
Liver cell
(FMA:63179)
|
854: Alterations, Cellular proliferation / hyperplasia
|
| 578 |
abnormal |
role
(MESH:D012380)
|
|
1108: Abnormal, Role change within caste
|
| 206 |
abnormal |
cellular homeostasis
(GO:0019725)
|
|
853: Changes/Inhibition, Cellular Homeostasis and Apoptosis
|
| 304 |
abnormal |
binding
(GO:0005488)
|
calcium ion
(CHEBI:39124)
|
1243: Altered, Ca2+-calmodulin activated signal transduction
|
| 302 |
abnormal |
foraging behavior
(GO:0060756)
|
|
560: Abnormal, Foraging activity and behavior
|
| 42 |
abnormal |
regulation of gene expression
(GO:0010468)
|
hippocampal formation
(UBERON:0002421)
|
756: Hippocampal gene expression, Altered
|
| 495 |
abnormal |
cardiovascular system development
(GO:0072358)
|
cardiovascular system
(UBERON:0004535)
|
317: Altered, Cardiovascular development/function
|
| 310 |
abnormal |
DNA repair
(GO:0006281)
|
Mitochondrial deoxyribonucleic acid
(FMA:67199)
|
664: Overwhelmed, Mitochondrial DNA repair mechanisms
|
| 581 |
abnormal |
wound healing
(GO:0042060)
|
|
1130: Failure in vascular repair mechanisms, Unresolved blood loss (hemorrhage)
|
| 136 |
abnormal |
multi-organism reproductive process
(GO:0044703)
|
|
253: N/A, Reproductive failure
|
| 269 |
abnormal |
anatomical structure development
(GO:0048856)
|
nervous system
(UBERON:0001016)
|
186: Altered, Neuroanatomy
|
| 143 |
abnormal |
developmental process
(GO:0032502)
|
reproductive organ
(UBERON:0003133)
|
364: Impaired development of, Reproductive organs
|
| 142 |
abnormal |
larval development
(GO:0002164)
|
|
2 Events
|
| 231 |
abnormal |
sex ratio
(MESH:D012744)
|
|
417: skewed, sex ratio
|
| 28 |
abnormal |
abnormal lipid homeostasis
(MP:0002118)
|
|
862: Not Increased, Circulating Ketone Bodies
|
| 289 |
abnormal |
regulation of steroid biosynthetic process
(GO:0050810)
|
|
652: Direct effects of Corticosterone on steroidogenesis, Decreased testosterone by adult Leydig cells
|
| 288 |
abnormal |
glucocorticoid receptor activity
(GO:0004883)
|
glucocorticoid receptor
(PR:000011406)
|
651: Glucocorticoid Receptor mediated alterations in steriodogenic enzymes, Decreased testosterone by adult Leydig cells
|
| 146 |
abnormal |
gene expression
(GO:0010467)
|
hemoglobin subunit alpha (human)
(PR:P69905)
|
21: Altered regulation, Alpha hemoglobin
|
| 580 |
abnormal |
hemostasis
(GO:0007599)
|
|
1122: Under carboxylated clotting factors will not assemble on cell surfaces to form clot, Failure of secondary hemostasis
|
| 317 |
abnormal |
developmental process
(GO:0032502)
|
|
577: impaired, Development
|
| 427 |
abnormal |
signaling
(GO:0023052)
|
hypoxia-inducible factor 1-alpha
(PR:000008555)
|
801: modulation, Unknown
|